|Home||» Products||» Antidiabetic Hypoglycemic Drugs||» Glimepiride|
- Minimum Order Quantity
GLIMCIP is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with type 2 diabetes (non-insulin-dependent diabetes mellitus ) whose hyperglycaemia cannot be controlled by diet and exercise alone. It should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.
- Main Export Market(s)
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia